Uterine lipoleiomyoma and lipoma: A rare unique case report
Published in the International Journal of Applied and Basic Medical Research, the authors report a unique case of a 43-year-old premenopausal woman with complaints of irregular vaginal bleeding and lower abdomen pain. Lipoleiomyoma in uterus corpus and cervical lipoma were diagnosed in hysterectomy specimen.

A 43-year-old premenopausal woman with Gravida 3 and Para 3 came to gynecology outpatient unit with complaints of irregular vaginal bleeding and lower abdomen pain since 6 months. There was no significant medical history. On clinical examination, vital signs were normal, and abdomen was soft with no palpable mass.

Abdominal and pelvic USG was performed and revealed heterogeneous echogenic mass each in uterine corpus (3.5 cm × 2.5 cm × 2.5 cm) and cervix (1.2 cm × 0.8 cm). A diagnosis of leiomyoma in uterine corpus and cervix with degenerative change was made. Surgical specimen of hysterectomy was received for histopathological examination.

Histopathology examination of the tumor from uterine corpus showed a tumor composed of lobules of mature adipocytes separated by fibrous septae. At places, thin bundles of smooth muscle cells were seen. Small sized normal blood vessels were seen in. There was no nuclear atypia or increased mitotic figures. A diagnosis of lipoleiomyoma was made. Histopathology of tumor from cervix revealed a tumor tissue composed of lobules of mature adipocytes, thick fibrous septae, and few entrapped mucosal glands. A diagnosis of pure lipoma was made.

Learning Points:-
-Lipoleiomyoma is a rare and commonly occurs in uterine corpus. Pure uterine lipoma is extremely rare.

- Although MRI can be a useful modality for preoperative diagnosis, most cases are diagnosed postoperatively on histopathology examination.

- These are benign neoplasms with excellent prognosis. Histogenesis is controversial.

- Coexistent gynecological malignancies and metabolic disorders in lipomatous uterine tumors warrant detail clinical, pathological evaluation, and follow-up.

Read more here: https://pxmd.co/JPz0Q